Nuzenio

Replimune Group

Replimune Group news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 15 publisher sources 100/100 entity strength

Latest news

Replimune Group Inc. (REPL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS NewswireACCESS Newswire · Sat, 08 Aug 2026 04:32:16 GMTReplimune Group Price Target Raised to $20.00/Share From $17.00 by JP Morgan - MoomooMoomoo · Sat, 08 Aug 2026 01:48:35 GMTReplimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling. -- Barrons.com - MoomooMoomoo · Sat, 08 Aug 2026 00:16:29 GMTWhy Is REPL Stock Soaring 127% After Hours Today? - StocktwitsStocktwits · Fri, 07 Aug 2026 22:37:50 GMTREPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with SBS Law - Business WireBusiness Wire · Fri, 07 Aug 2026 21:07:00 GMTAmid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial - The Cancer LetterThe Cancer Letter · Fri, 07 Aug 2026 20:50:43 GMTReplimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling. - Barron'sBarron's · Fri, 07 Aug 2026 19:33:00 GMTFDA Grants Accelerated Approval to Replimune's Tudriqev Plus Nivolumab for Advanced Melanoma - BioPharm InternationalBioPharm International · Fri, 07 Aug 2026 17:19:39 GMT

Timeline

Sat, 08 Aug 2026 04:32:16 GMTReplimune Group Inc. (REPL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Sat, 08 Aug 2026 01:48:35 GMTReplimune Group Price Target Raised to $20.00/Share From $17.00 by JP Morgan - Moomoo
Sat, 08 Aug 2026 00:16:29 GMTReplimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling. -- Barrons.com - Moomoo
Fri, 07 Aug 2026 22:37:50 GMTWhy Is REPL Stock Soaring 127% After Hours Today? - Stocktwits
Fri, 07 Aug 2026 21:07:00 GMTREPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with SBS Law - Business Wire
Fri, 07 Aug 2026 20:50:43 GMTAmid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial - The Cancer Letter

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Replimune Group.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

15 distinct publisher/source names are currently connected to this entity page.